Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.

In a blind study, 518 serum samples were assayed for serum levels of mammary serum antigen (MSA) by an enzyme immunoassay (EIA) using the 3E1.2 monoclonal antibody. Using 300 IU as the arbitrary cut off to distinguish normal from abnormal individuals, 75% of patients with primary Stage I carcinoma o...

Descripción completa

Detalles Bibliográficos
Autores principales: Stacker, S. A., Sacks, N. P., Golder, J., Tjandra, J. J., Thompson, C. H., Smithyman, A., McKenzie, I. F.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1988
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246506/
https://www.ncbi.nlm.nih.gov/pubmed/3355770

Ejemplares similares

Ejemplares similares